ID 1128 -
Kwas dokozaheksaenowy, Kwas eikozapentaenowy
PL: Kwas dokozaheksaenowy, Kwas eikozapentaenowy
EN: DHA+EPA - long chain omega 3 fatty acids
Pdf: eicosapentaenoic acid
Oświadczenie (4)
- EPA i DHA przyczyniają się do prawidłowego funkcjonowania serca
Oświadczenie (2)
- układu krążenia
- oka, mózgu i serca zdrowia
- układu krążenia: utrzymania i promocji zdrowia serca i krążenia zdrowy
- zdrowie serca
- normalne funkcjonowanie układu krążenia
1. Charakterystyka żywności / składnika
The food constituent which is the subject of the health claims is mixed long-chain n-3 polyunsaturated fatty acids (n-3 LCPUFA), namely docosahexaenoic acid (DHA) in combination with eicosapentaenoic acid (EPA) and, for ID 703, with docosapentaenoic acid (DPA).
The n-3 LCPUFA EPA, DHA and DPA are recognised nutrients and are measurable in foods by established methods. They are well absorbed when consumed in the form of triglycerides. This evaluation applies to EPA, DHA and, for ID 703, DPA from all sources with suitable bioavailability in the specified amounts.
The Panel considers that the food constituent, EPA, DHA and DPA, which is the subject of the health claims, is sufficiently characterised.
2.1. Utrzymanie prawidłowego funkcjonowania serca (ID 504, 506, 516, 527, 538, 703, 1128, 1317, 1324, 1325)
The claimed effects are “cardiovascular system: maintenance and promotion of heart health and healthy circulation”, “normal cardiovascular function”, “eye, brain and heart health”, “cardiovascular health” and “heart health”. The Panel assumes that the target population is the general population.
In the context of the proposed wordings and clarifications provided by Member States, the Panel notes that the claimed effects relate to the maintenance of normal cardiac function.
The Panel considers that maintenance of normal cardiac function is a beneficial physiological effect.
3.1. Utrzymanie prawidłowego funkcjonowania serca (ID 504, 506, 516, 527, 538, 703, 1128, 1317, 1324, 1325)
National and international bodies have based their recommendations for dietary intake of EPA and DHA on the inverse relationship observed between the consumption of these long-chain n-3 PUFAs (primarily from fish and fish oils) and a lower risk of coronary artery disease. Such recommendations range from 200 mg to 500 mg per day (EFSA, 2005, 2009; EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2010). Most recent evidence derived from meta-analyses of randomised trials and large prospective studies shows that, when only healthy subjects are considered, the intake of EPA plus DHA is negatively related to coronary heart disease mortality in a dose- dependent way up to about 250 mg per day (1–2 servings of oily fish per week), with little additional
benefit observed at higher intakes (Mozaffarian and Rimm, 2006; Mozaffarian, 2008; Harris et al., 2008, 2009a, b; EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2010).
EPA and DHA intakes could reduce the risk of coronary heart disease mortality by different (but often overlapping) mechanisms (e.g. through antiarrhythmic and antithrombotic effects, by reducing blood pressure, heart rate and plasma concentrations of triglycerides), and the doses of EPA and DHA (100->2,500 mg/d) as well as the time required to observe clinical effects and/or alter clinical events (weeks to years) through each mechanism may vary widely (Mozaffarian and Rimm, 2006).
The Panel concludes that a cause and effect relationship has been established between the consumption of EPA and DHA and maintenance of normal cardiac function.
4.1. Utrzymanie prawidłowego funkcjonowania serca (ID 504, 506, 516, 527, 538, 703, 1128, 1317, 1324, 1325)
The Panel considers that the following wording reflects the scientific evidence: “EPA and DHA contribute to the normal function of the heart”.
5.1. Utrzymanie prawidłowego funkcjonowania serca (ID 504, 506, 516, 527, 538, 703, 1128, 1317, 1324, 1325)
The Panel considers that intakes of EPA and DHA of about 250 mg per day are required to obtain the claimed effect. Such an amount can be consumed as part of a balanced diet. The target population is the general population.
Warunki i możliwe ograniczenia stosowania oświadczenia
Two portions per week, at least one oily